Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,696 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.
Arora S, Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Sigurdardottir V, Dellgren G, Erikstad I, Solberg OG, Ueland T, Aukrust P, Gullestad L; SCHEDULE (SCandinavian HEart transplant everolimus De novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators. Arora S, et al. Among authors: andersson b. Am J Transplant. 2015 Jul;15(7):1967-75. doi: 10.1111/ajt.13214. Epub 2015 Mar 17. Am J Transplant. 2015. PMID: 25783974 Free article. Clinical Trial.
Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial.
Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Radegran G, Gude E, Jansson K, Solbu D, Sigurdardottir V, Arora S, Dellgren G, Gullestad L; SCHEDULE Investigators. Andreassen AK, et al. Among authors: andersson b. Am J Transplant. 2014 Aug;14(8):1828-38. doi: 10.1111/ajt.12809. Am J Transplant. 2014. PMID: 25041227 Free article. Clinical Trial.
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study.
Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Rådegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L; SCHEDULE investigators. Andreassen AK, et al. Among authors: andersson b. Am J Transplant. 2016 Apr;16(4):1238-47. doi: 10.1111/ajt.13588. Epub 2016 Jan 28. Am J Transplant. 2016. PMID: 26820618 Free article. Clinical Trial.
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study.
Gustafsson F, Andreassen AK, Andersson B, Eiskjær H, Rådegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L; SCHEDULE (Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance) Investigators*. Gustafsson F, et al. Among authors: andersson b. Transplantation. 2020 Jan;104(1):154-164. doi: 10.1097/TP.0000000000002702. Transplantation. 2020. PMID: 30893292 Clinical Trial.
Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudy.
Nelson LM, Andreassen AK, Arora S, Andersson B, Gude E, Eiskjaer H, Rådegran G, Dellgren G, Gullestad L, Gustafsson F. Nelson LM, et al. Among authors: andersson b. Transpl Int. 2020 May;33(5):517-528. doi: 10.1111/tri.13577. Epub 2020 Feb 9. Transpl Int. 2020. PMID: 31958178 Free article. Clinical Trial.
Hypertension is associated with increased mortality in patients with ischaemic heart disease after revascularization with percutaneous coronary intervention - a report from SCAAR.
Saluveer O, Redfors B, Angerås O, Dworeck C, Haraldsson I, Ljungman C, Petursson P, Odenstedt J, Ioanes D, Lundgren P, Völz S, Råmunddal T, Andersson B, Omerovic E, Bergh N. Saluveer O, et al. Among authors: andersson b. Blood Press. 2017 Jun;26(3):166-173. doi: 10.1080/08037051.2016.1270162. Epub 2017 Jan 16. Blood Press. 2017. PMID: 28092977
1,696 results